| Literature DB >> 34195666 |
Eric M Milliron1, Robert A Magnussen2,3, Parker A Cavendish1, John P Quinn1, Alex C DiBartola2, David C Flanigan2,3,4.
Abstract
PURPOSE: To quantify healing rates and patient-reported outcome scores following repair of radial meniscus tears.Entities:
Year: 2021 PMID: 34195666 PMCID: PMC8220631 DOI: 10.1016/j.asmr.2021.03.002
Source DB: PubMed Journal: Arthrosc Sports Med Rehabil ISSN: 2666-061X
Fig 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram outlining algorithm for study inclusion and exclusion.
Coleman Methodology Score for Each Included Study to Assess Study Design, Methodology, and Quality of Outcome Reporting
| Study | Study Size | Mean Follow-Up | Number of Interventions Per Group | Type of Study | Diagnostic Certainty | Description of Surgical Technique | Description of Postoperative Rehabilitation | Outcome Measures Clearly Defined | Timing of Outcome Assessment Clear | Use of Outcome Criteria With Reported Good Reliability | Use of Outcome With Good Sensitivity | Subjects Recruited | Independent Investigator (2 For Radiographic, 2 For Clinical) | Written Assessment | Completion of Assessment by Subjects Themselves With Minimal Investigator Assistance | Selection Criteria Reported and Unbiased | Recruitment Rate Reported And ≥80% | Eligible Subjects Not Included in Study Satisfactorily Accounted for | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Song et al. (2014) | 0 | 5 | 7 | 0 | 5 | 5 | 10 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 47 |
| Anderson et al. | 0 | 5 | 7 | 0 | 5 | 5 | 0 | 2 | 0 | 3 | 3 | 0 | 0 | 3 | 3 | 0 | 0 | 5 | 41 |
| Ra et al. | 0 | 5 | 10 | 0 | 5 | 5 | 10 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 50 |
| Haklar et al. | 0 | 5 | 10 | 10 | 5 | 5 | 10 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 60 |
| Choi et al. | 0 | 5 | 10 | 10 | 5 | 5 | 10 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 60 |
| Wu et al. | 4 | 5 | 0 | 0 | 5 | 5 | 5 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 39 |
| Cinque et al. | 4 | 5 | 7 | 10 | 5 | 5 | 5 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 56 |
| Tsujii et al. | 7 | 5 | 7 | 0 | 5 | 5 | 5 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 49 |
| Gan et al. | 4 | 2 | 0 | 0 | 5 | 0 | 0 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 26 |
| Piontek et al. | 7 | 5 | 7 | 10 | 5 | 5 | 5 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 59 |
| Nakata et al. | 4 | 2 | 7 | 0 | 5 | 5 | 5 | 2 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 43 |
| Chen et al. | 0 | 5 | 10 | 0 | 5 | 3 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 32 |
Bias Assessment Using the Cochrane Risk of Bias in Non-Randomized Studies - of Interventions (ROBINS-I) Tool
| Study | Risk of Bias due to Confounding | Risk of Bias in Selection | Risk of Bias in Classification of Interventions | Risk of Bias due to Deviations From Intended Interventions | Risk of Bias due to Missing Data | Risk of Bias in Measurement of Outcomes | Risk of Bias in Selection of the Reported Result | Overall Risk of Bias |
|---|---|---|---|---|---|---|---|---|
| Song et al. (2014) | Serious | Moderate | Moderate | Low | Low | Moderate | Low | Serious |
| Anderson et al. | Serious | Serious | Moderate | Low | Low | Moderate | Low | Serious |
| Ra et al. | Serious | Low | Low | Low | Low | Moderate | Low | Serious |
| Haklar et al. | Low | Low | Low | Low | Low | Moderate | Low | Moderate |
| Choi et al. | Serious | Serious | Moderate | Low | Low | Low | Low | Serious |
| Wu et al. | Moderate | Moderate | Moderate | Moderate | Low | Low | Low | Moderate |
| Cinque et al. | Serious | Moderate | Moderate | Moderate | Low | Low | Low | Serious |
| Tsujii et al. | Low | Moderate | Moderate | Low | Low | Low | Low | Moderate |
| Gan et al. | Serious | Serious | Moderate | Low | Low | Moderate | Moderate | Serious |
| Piontek et al. | Moderate | Moderate | Moderate | Low | Moderate | Moderate | Low | Moderate |
| Nakata et al. | Serious | Moderate | Moderate | Serious | Moderate | Low | Low | Serious |
| Chen et al. | Serious | Moderate | Moderate | Low | Low | Moderate | Low | Serious |
-Low risk of bias: the study is comparable with a well-performed randomized trial. The study is judged to be at low risk of bias for all domains.
-Moderate risk of bias: the study appears to provide sound evidence for a non-randomized study but cannot be considered comparable to a well-performed randomized trial. The study is judged to be at low or moderate risk of bias for all domains.
-Serious risk of bias: the study has some important problems. The study is judged to be at serious risk of bias in at least 1 domain, but not at critical risk of bias in any domain.
-Critical risk of bias: the study is too problematic to provide any useful evidence and should not be included in any synthesis. The study is judged to be at critical risk of bias in any domain.
Per the ROBINS-I detailed guide, each bias domain and the overall risk of bias is defined as:
Fig 2Forest plot of preoperative Lysholm knee scores. (CI, confidence interval; ES, effect size.)
Fig 3Forest plot of postoperative Lysholm knee scores. (CI, confidence interval; ES, effect size.)
Fig 4Forest plot of preoperative Tegner knee scores. (CI, confidence interval; ES, effect size.)
Fig 5Forest plot of postoperative Tegner knee scores. (CI, confidence interval; ES, effect size.)
Fig 6Forest plot of preoperative IKDC knee scores. (CI, confidence interval; ES, effect size; IKDC, International Knee Documentation Committee;)
Fig 7Forest plot of postoperative IKDC knee scores. (CI, confidence interval; ES, effect size; IKDC, International Knee Documentation Committee;)
Study Design
| Study | Year | Journal | Study Design (Level of Evidence) | Sample Size (After Loss to Follow-Up) | Preoperative Diagnosis | Postoperative Diagnosis |
|---|---|---|---|---|---|---|
| Song et al. | 2014 | Retrospective case series (Level IV) | 15 | Clinical, arthroscopy | Clinical, arthroscopy | |
| Anderson et al. | 2010 | Retrospective case series (Level IV) | 24 (8 radial) | Clinical, arthroscopy | Clinical | |
| Ra et al. | 2013 | Retrospective case series (Level IV) | 12 | Clinical, arthroscopy | Clinical, mri | |
| Haklar et al. | 2008 | Prospective case series (Level IV) | 5 | Clinical, MRI | Clinical, MRI | |
| Choi et al. | 2010 | Retrospective case series (Level IV) | 14 | Clinical, MRI, arthroscopy | Clinical, MRI | |
| Wu et al. | 2018 | Retrospective cohort (Level III) | 24 | Clinical, arthroscopy | Clinical | |
| Cinque et al. | 2017 | Retrospective cohort (Level III) | 27 in radial repair; 33 in vertical repair | Clinical, MRI | Clinical | |
| Tsujii et al. | 2019 | Retrospective case–control (Level III) | 41 in study group; 98 in control | Clinical, MRI, arthroscopy | Clinical, MRI, second-look arthroscopy (30) | |
| Gan et al. | 2020 | Retrospective cohort (Level III) | 15 | Clinical, arthroscopy | Clinical | |
| Piontek et al. | 2016 | Retrospective case series (Level IV) | 46 | Clinical, arthroscopy | Clinical, MRI | |
| Nakata et al. | 2012 | Retrospective cohort (Level III) | 29 | Clinical, arthroscopy | Clinical, arthroscopy | |
| Chen et al. | 2011 | Retrospective cohort (Level III) | 7 | Arthroscopy, MRI | Clinical, arthroscopy |
MRI, magnetic resonance imaging; NR, not recorded.
Patient Characteristics
| Study | Initial Sample Size | Knees With Follow-Up (%) | Mean Follow-Up | Lost to Follow-Up | Mean Age, y | Sex (Male) | Laterality | Meniscus Involved | Tear Grade | No. With Previous Surgery | No. With Concomitant ACLR | Mean Duration of Symptoms | Mean Time to Surgery |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Song et al. | NR | 15 (NR%) | 24 months (12-46) | NR | 34.5 (18-56) | 12 | NR | 15 Lateral | NR | NR | 15 | NR | 3.3 months |
| Anderson et al. | 8 | 8 (100%) | 70.5 months (29-168) | 0 | NR | 5 | 3 Left | 8 Lateral | NR | NR | 8 | NR | 22.4 months |
| Ra et al. | 27 | 12 (44%) | 30 months (26-34) | 27 total at beginning (15 lost to follow-up) | NR | 11 | NR | 9 Lateral | NR | NR | 2 | NR | NR |
| Haklar et al. | 5 | 5 (100%) | 31 Months (12-46) | 0 | 28.6 (17-35) | NR | 3 Left | 5 Lateral | NR | NR | 0 | 2 weeks | 2 weeks |
| Choi et al. | 21 | 14 (67%) | 36.3 months (24-54) | 21 total at beginning (7 lost to follow-up) | 29.9 (16-52) | 11 | NR | 14 Lateral | NR | NR | 0 | 6 months 3 days | 6.75 months |
| Wu et al. | 38 | 31 (82%) | 42 months (24-76) | 7 | 22.8 ± 11.9 | 18 | NR | 28 Lateral | NR | 0 | 16 | NR | 48 ± 62 days |
| Cinque et al. | 27 | 27 (100%) | 42 months (24-65) | 0 | 35.1 (18-67) | 19 | 16 Left | 1 Lateral | NR | 0 | 17 | NR | NR |
| Tsujii et al. | 41 | 41 (100%) | 41 months | 0 | 29.5 (14-57) | 18 | NR | NR | NR | NR | 41 | NR | 124.8 days |
| Gan et al. | 15 | 15 (100%) | 22.4 months | 0 | 42 | NR | NR | NR | NR | NR | NR | NR | NR |
| Piontek et al. | 58 | 53 (91%) | >24 months | 3 (2 others dropped from study due to data missing | 36.7 (18-59) | 36 | 21 Left | 15 Lateral | NR | NR | 21 | NR | 21.9 months |
| Nakata et al. | 35 | 29 (88%) | 18 months (12-26) | 33 initially, 6 lost to follow-up | 25.5 (16-42) | 17 | NR | 18 Lateral | Type A: 2 | 0 | 21 | NR | 8 months |
| Chen et al. | 7 | 7 (100%) | NR | NR | NR | NR | NR | 7 Lateral | NR | NR | NR | NR | NR |
NOTE. None of the studies reported on tear site.
ACLR, anterior cruciate ligament reconstruction; NR, not recorded.
Study Surgical Techniques and Protocols
| Study | Fixation Approach | Sutures Used | Mean No. of Sutures | Adjuncts Used | Weight-Bearing Restrictions | ROM Restrictions | Return to Sport |
|---|---|---|---|---|---|---|---|
| Song et al. | Arthroscopic, all-inside, side-to-side approach | No. 0 PDS | NR | None | NWB, 4 weeks | 0-90 for 4 weeks | NR |
| Anderson et al. | Arthroscopic, inside-out; all-inside technique in some | NR | 1.9 ± 1.1 | None | NR | NR | NR |
| Ra et al. | Arthroscopic, inside-out repair | Horizontal, 2-0 Polyester Braided Suture (Ethicon) | NR | Fibrin clot | NWB, 6 weeks | Immobilized in extension for 3 weeks in some; CPM 3 days postoperative in other | NR |
| Haklar et al. | arthroscopic, inside-out approach, using zone-specific curved cannula | Nos. O and 2 ETHIBOND sutures (Ethicon) | 2.4 superior, 2.8 inferior | None | NWB, 6-8 weeks | Immobilized for 6-8 weeks | 4-5 months |
| Choi et al. | arthroscopic, all-inside | No. 1 PDS | 1 or 2 | None | Toe-touch weight bearing, 6 weeks. | 0-90 for 6 weeks | 6 months |
| Wu et al. | arthroscopic, inside-out (7) or all-inside technique (16) or hybrid (1) | No. 2 Ethicon | NR | Platelet-rich fibrin matrix (3) | NWB, 4 weeks | 0-90 for 4 weeks | 4 months |
| Cinque et al. | Two-tunnel, transtibial pullout repair | No. 2 nonabsorbable suture (ULTRABRAID); 2-0 non-absorbable horizontal mattress to reinforce | NR | Marrow-venting procedure (10) | NWB, 6 weeks | 0-90 for 2 weeks, then progress as tolerated | 4 months |
| Tsujii et al. | arthroscopic, inside-out (29) or all-inside (12) technique | No 2-0 braided polyester suture | NR | None | NWB, 3-4 weeks | Immobilized for 1 week, then ROM started | 8-9 months |
| Gan et al. | NR | NR | NR | NR | NR | NR | NR |
| Piontek et al. | Arthroscopic, all-inside | ETHIBOND 2, #2-0, braided, uncoated, UHMW polyethylene with monofilament polypropylene cobraid nonabsorbable suture | NR | Collagen membrane (Chondro-Gide) wrapping with bone marrow injection | partial weight-bearing at 2-4 weeks | ROM exercises on first postoperative day | 6 months |
| Nakata et al. | arthroscopic inside out | 2-0 ETHIBOND sutures | 5 or 6 | autogenous fibrin clot (unless concomitant ACLR) | NWB, 4 weeks, PWB until 6 weeks, | 6 months | |
| Chen et al. | NR | NR | NR | NR | NR | NR |
CPM, continuous passive motion; NR, not recorded; NWB, non–weight-bearing; PDS, p-dioxanone ROM, range of motion; UHMW, ultra high molecular weight polyethylene.
Outcome Assessments Used
| Study | Physical Exam | Lysholm | Tegner | IKDC Subjective | Arthroscopy | MRI | WOMAC | Visual Analog | SF-12 | Ikeuchi |
|---|---|---|---|---|---|---|---|---|---|---|
| Song. et al. | X | X | X | X | ||||||
| Anderson et al. | X | X | X | |||||||
| Ra et al. | X | X | X | X | ||||||
| Haklar et al. | X | X | ||||||||
| Choi et al. | X | X | X | X | X | |||||
| Wu et al. | X | X | X | X | ||||||
| Cinque et al. | X | X | X | X | ||||||
| Tsujii et al. | X | X | X | |||||||
| Gan et al. | X | X | ||||||||
| Piontek et al. | X | X | X | X | ||||||
| Nakata et al. | X | X | ||||||||
| Chen et al. | X |
IKDC, International Knee Documentation Committee; MRI, magnetic resonance imaging; SF-12, Short Form Health Survey; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Patient-Reported Outcomes
| VAS | IKDC | Tegner | WOMAC | Lysholm | Ikeuchi (Good/Excellent) | SF-12 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | ||
| Song. et al. | 3.1 ± 0.8 | 6.7 ± 1.4 | 68.9 ± 4.3 | 95.6 ± 3.5 | |||||||||
| Anderson et al. | 1.2 ± 1.0 | 81.6 ± 6.8 | 6.0 ± 1.3 | 86.9 ± 5.7 | |||||||||
| Ra et al. | 57 ± 7 | 92 ± 3 | 65 ± 6 | 94 ± 3 | |||||||||
| Haklar et al. | 61.8 ± 5.4 | 94.2 ± 3.2 | |||||||||||
| Choi et al. | 4.0 (1–8) | 5.7 (3–7) | 73.7 (36–90) | 94.7 (81–100) | |||||||||
| Wu et al. | 5.8 ± 2.9 | 0.8 ± 1.5 | 39.8 ± 12.3 | 89.0 ± 13.1 | 2.6 ± 1.4 | 6.5 ± 1.5 | |||||||
| Cinque et al. | 1 (0-9) | 6 (5-7) | 37 ± 21 | 4 (1-13) | 47 ± 22 | 91 (74-96) | 37 ± 9 | 55 (48-57) | |||||
| Tsujii et al. | |||||||||||||
| Gan et al. | 41.1 ± 16.2 | 83.4 ± 16.4 | 2.5 ± 1.3 | 4.7 ± 1.1 | |||||||||
| Piontek et al. | 44.5 ± 5.2 | 79.1 ± 9.1 | 66.1 ± 6.2 | 86.4 ± 5.1 | |||||||||
| Nakata et al. | |||||||||||||
| Chen et al. | 42.90% | ||||||||||||
| Wu et al. | 4.1 ± 2.4 | 0.4 ± 0.8 | 36.3 ± 16.3 | 93.1 ± 3.3 | 1.9 ± 0.6 | 6.6 ± 1.6 | |||||||
| Cinque et al. | 2 (0-10) | 6 (4-6) | 40 ± 24 | 7 (1-12) | 46 ± 22 | 83 (73-95) | 37 ± 10 | 56 (46-58) | |||||
| Tsujii et al. | |||||||||||||
| Gan et al. | 45.2 ± 24 | 82.5 ± 22.5 | 2.9 ± 1.4 | 5.1 ± 1.6 | |||||||||
IKDC, International Knee Documentation Committee; SF-12, Short Form Health Survey; VAS, visual analog scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Healing Rates
| Study | Evaluation Method | Complete Healing | Partial Healing | Failure | Total |
|---|---|---|---|---|---|
| Song et. al | Second-look arthroscopy | 9 (60%) | 4 (27%) | 2 (13%) | 15 |
| Ra et al. | Second-look arthroscopy | 6 (86%) | 1 (14%) | 0 (0%) | 7 |
| Tsujii et al. | Second-look arthroscopy | 18 (60%) | 9 (30%) | 3 (10%) | 30 |
| Nakata et al. | Second-look arthroscopy | 19 (66%) | 8 (28%) | 2 (7%) | 29 |
| Haklar et al. | MRI | 5 (100%) | 0 (0%) | 0 (0%) | 5 |
| Choi et al. | MRI | 5 (36%) | 8 (57%) | 1 (7%) | 14 |
MRI, magnetic resonance imaging.